BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 23505090)

  • 41. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.
    Wong N; Lai P; Lee SW; Fan S; Pang E; Liew CT; Sheng Z; Lau JW; Johnson PJ
    Am J Pathol; 1999 Jan; 154(1):37-43. PubMed ID: 9916916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.
    Boyault S; Rickman DS; de Reyniès A; Balabaud C; Rebouissou S; Jeannot E; Hérault A; Saric J; Belghiti J; Franco D; Bioulac-Sage P; Laurent-Puig P; Zucman-Rossi J
    Hepatology; 2007 Jan; 45(1):42-52. PubMed ID: 17187432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
    Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
    J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation.
    Haines K; Sarabia SF; Alvarez KR; Tomlinson G; Vasudevan SA; Heczey AA; Roy A; Finegold MJ; Parsons DW; Plon SE; López-Terrada D
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27745. PubMed ID: 30977242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.
    Ma NF; Hu L; Fung JM; Xie D; Zheng BJ; Chen L; Tang DJ; Fu L; Wu Z; Chen M; Fang Y; Guan XY
    Hepatology; 2008 Feb; 47(2):503-10. PubMed ID: 18023026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
    Buckley AF; Burgart LJ; Kakar S
    Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
    Chappell G; Silva GO; Uehara T; Pogribny IP; Rusyn I
    Cancer Med; 2016 Mar; 5(3):574-85. PubMed ID: 26778414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.
    Steinemann D; Skawran B; Becker T; Tauscher M; Weigmann A; Wingen L; Tauscher S; Hinrichsen T; Hertz S; Flemming P; Flik J; Wiese B; Kreipe H; Lichter P; Schlegelberger B; Wilkens L
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1283-91. PubMed ID: 16979954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
    Law PT; Ching AK; Chan AW; Wong QW; Wong CK; To KF; Wong N
    Carcinogenesis; 2012 Jun; 33(6):1134-41. PubMed ID: 22431718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome-wide analysis of genetic variations assisted by Ingenuity Pathway Analysis to comprehensively investigate potential genetic targets associated with the progression of hepatocellular carcinoma.
    Yu F; Shen XY; Fan L; Yu ZC
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2102-8. PubMed ID: 25070813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomics and signaling pathways in hepatocellular carcinoma.
    Villanueva A; Newell P; Chiang DY; Friedman SL; Llovet JM
    Semin Liver Dis; 2007 Feb; 27(1):55-76. PubMed ID: 17295177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
    Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
    Takeda H; Takai A; Kumagai K; Iguchi E; Arasawa S; Eso Y; Shimizu T; Ueda Y; Taura K; Uemoto S; Kita R; Haga H; Marusawa H; Fujimoto A; Seno H
    J Pathol; 2020 Dec; 252(4):398-410. PubMed ID: 32815153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The emerging role of astrocyte-elevated gene-1 in hepatocellular carcinoma (Review).
    Zhu HD; Liao JZ; He XX; Li PY
    Oncol Rep; 2015 Aug; 34(2):539-46. PubMed ID: 26035424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.
    Hlady RA; Zhou D; Puszyk W; Roberts LR; Liu C; Robertson KD
    Epigenetics; 2017 Mar; 12(3):215-225. PubMed ID: 28059585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrative molecular analysis of metastatic hepatocellular carcinoma.
    Wang D; Zhu Y; Tang J; Lian Q; Luo G; Wen W; Zhang MQ; Wang H; Chen L; Gu J
    BMC Med Genomics; 2019 Nov; 12(1):164. PubMed ID: 31722693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.